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Purpose: This study aims to evaluate the medium-term outcomes
following aortic aneurysm repair using fenestrated endografts performed in
16 French academic centres.
Materials and methods: A retrospective analysis of prospectively
collected data was carried out. This study included all patients treated with
fenestrated endografts in France between May 2004 and January 2009.
Patients were judged to be at high risk for open surgical repair. Fenestrated
endografts were designed using computed tomography (CT) reconstruc-
tions performed on three-dimensional (3D) workstations. All patients were
evaluated with CT, duplex ultrasound and plain film radiograph at dis-
charge, 6, 12, 18 and 24 months, and annually thereafter.
Results:A total of 134 patients (129males) were treated over the study
period. Median age and aneurysm size were 73 years (range 48–91 years)
and 56 mm (range 45–91 mm), respectively. A total of 403 visceral vessels
were perfused through a fabric fenestration, including 265 renal arteries.
One early conversion to open surgery was required. Completion angiogra-
phy and discharge CT scan showed that 398/403 (99%) and 389/394
(99%) respective target vessels were patent. The 30-daymortality rate was 2%
(3/134). Pre-discharge imaging identified 16 (12%) endoleaks: three type I,
12 type II and one type III. After the procedure, transient or permanent
dialysis was required in four (3%) and two (1%) patients, respectively. The
median duration of follow-up was 15 months (range 2–53 months). No
aneurysms ruptured or required open conversion during the follow-up
period. Twelve of 131 patients (9%) died during follow-up (actuarial survival
at 12 and 24 months: 93% and 86%, respectively). Median time from
procedure to death was 15 months. None of these deaths were aneurysm
related. Aneurysm sac size decreased by more than 5 mm in 52%, 65.6% and
75% of patients at 1, 2 and 3 years, respectively. Three (4%) patients had sac
enlargement within the first year, associated with a persistent endoleak.
During follow-up, four renal artery occlusions were detected. A total of 12
procedure-related re-interventions were performed in 12 patients during
follow-up, including six to correct endoleaks, and five to correct threatened
visceral vessels.
Conclusions: The use of endovascular prostheses with graft material
incorporating the visceral arteries is safe and effective in preventing rupture
in the medium term. A predictable high mortality rate was depicted during
follow-up in this high-risk cohort. Meticulous follow-up to assess sac behav-
iour and visceral ostia is critical to ensure optimal results.
Secondary Interventions Following Endovascular Aneurysm Repair
(EVAR) and the Enduring Value of Graft Surveillance
Nordon I.M., Karthikesalingam A., Hinchliffe R.J., Holt P.J., Loftus I.M.,
Thompson M.M. Eur J Vasc Endovasc Surg 2010;39:in press.
Objective: Lifelong imaging surveillance is currently recommended for
all patients following endovascular aortic aneurysm repair (EVR). The
modality, timing and overall necessity of surveillance has recently been
brought into question. This review reports contemporary secondary inter-
vention rates and explores surveillance imaging pick-up rates and reports
the evidence supporting modified EVR surveillance programs.
Design: Systematic review of literature (2002–2009) andmeta-analysis
of Kaplan–Meier re-intervention-free survival estimates.
Results: 32 Papers were included in final analysis. 17,987 EVR cases
were reported. Crude annual secondary intervention rates from the US
population registries were 3.7%/year (range 1.7–4.3%). Combined re-
intervention-free survival estimates, from 14 series (10,365 cases), demon-
strated a linear progression with 89.9%, 86.9% and 81.5% of grafts without
secondary procedures at 2, 3 and 5 years respectively.
3 Reports (1249 cases) differentiated between interventions directed
by surveillance or outside surveillance protocols. Surveillance imaging alone
initiated the secondary interventions in 1.4–9% of cases;90% of EVR cases
received no benefits from surveillance scans.
Discussion: Some format of surveillance following EVR probably
remains necessary despite a reduction in secondary interventions with mod-
ern stent-grafts. Surveillance should be targeted at those stent-grafts and
patients at high risk of complications. Further work is justified to identify this
group.Different Effects of Commonly Prescribed Statins on Abdominal Aor-
tic Aneurysm Wall Biology
Hurks R., Hoefer I.E., Vink A., Pasterkamp G., Schoneveld A., Kerver M.,
de Vries J.-P.PM., Tangelder M.J., Moll F.L. Eur J Vasc Endovasc Surg
2010;39:in press.
Background: Pharmaceutical stabilisation of the abdominal aortic
aneurysm (AAA) wall can delay surgery and improve outcome. Observa-
tional studies indicate statins can be used to reduce AAA growth but
mechanistic data are scarce. In this study, our aim was to determine the
pleiotropic effects of different statins on AAA wall composition.
Methods: We included 216 patients undergoing open AAA repair, of
which 60 used simvastatin, 52 atorvastatin and 23 pravastatin. The AAAwall
histology and protein expression (IL 1,2,4,5,6,8,10,12, interferon-gamma
(IFN), tumour necrosis factor (TNF),, matrix metalloproteinase
(MMP)2 and 9 activities, total MMP8,9 and cathepsin A and B levels)
between statin users and non-users were compared as also among the use of
different statins.
Results: As far as histological inflammation goes, the AAA walls of
statin users did not differ from those not using them. After multivariate
adjustment for risk factors, pravastatin use was associated with tendencies of
increased MMP8 (p  0.022), active MMP9 (p  0.040) and higher ca-
thepsin B (p  0.056) levels. The AAA walls of simvastatin and atorvastatin
users showed no differences in proteases or cytokines in multivariate analy-
ses.
Conclusions: The use of statins was not associated with a decrease in
protease levels or inflammation. The trends of elevated protease levels
associated with pravastatin use suggest pleiotropic differences among the
various statins, supporting the need for further research to target pharma-
ceutical AAA treatment.
Interobserver Agreement of the TASC II Classification for Supra- and
Infrainguinal Lesions
Zimmermann A., Wendorff H., Schuster T., Auer F., Berger H., Eckstein
H.-H. Eur J Vasc Endovasc Surg 2010;39:in press.
Objectives: The Trans-Atlantic Inter-Society Document on Manage-
ment of Peripheral Arterial Disease (TASC) gives treatment recommenda-
tions depending on the classification of aorto-iliacal or femoro-popliteal
vascular pathologies. Therefore, the best treatment could only be offered if
the right TASC classification was obtained. The purpose of this study was to
assess the interobserver agreement of the evaluation of the TASC II classi-
fication for peripheral arterial occlusive disease (PAOD) in magnetic reso-
nance angiography (MRA).
Patients and methods: Three hundred arterial segments of 149 pa-
tients with a magnetic MRA for PAOD were evaluated according to the
TASC II classification. A resident and a consultant for radiology and vascular
surgery both performed independent grading. A comparative assessment of
the consensus agreement was quantified by the marginal probabilities calcu-
lated by generalised estimation equation models, as well as by using the
weighted kappa coefficient (), classified according to Altman.
Results: In relation to the consensus, the overall agreement was good
to excellent for the consultants of radiology and vascular surgery. The
consultants obtained a statistically significant higher agreement than did the
residents (Odds ratio (OR): 2.86, 95% confidence interval (CI): 2.21–3.69,
p  0.001). A significantly higher consensus agreement probability was
observed for the surgeons compared with the radiologists (OR: 1.43, 95%
CI: 1.11–1.84, p  0.006) and for the femoro-popliteal regions compared
with the aorto-iliacal regions (OR: 1.64, 95% CI: 1.12–2.14, p  0.012).
Conclusion: Although good results can be achieved in the assessment
of vascular lesions according to the TASC II document, a simplification of
this classification could increase its practicability in a daily clinical routine.
Predictive Risk Factors for Restenosis after Remote Superficial Femoral
Artery Endarterectomy
DerksenW.J.M., Gisbertz S.S., Hellings W.E., Vink A., de Kleijn D.P.V., de
Vries J.-P.P.M., Moll F.L., Pasterkamp G. Eur J Vasc Endovasc Surg
2010;39:in press.Objectives: Restenosis following remote superficial femoral artery
endarterectomy (RSFAE) remains a challenging problem. The determinants
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